Target intelligence / Profile preview

Cerumen lipid and keratin aggregates

Molecular classification
Lipid-protein aggregate, Biological secretion, Other
01

Overview

Cerumen lipid and keratin aggregates, commonly referred to as earwax, are complex physiological substances found in the external auditory canal. They are composed of a mixture of desquamated keratinocytes (keratin) and secretions from sebaceous and ceruminous glands, containing lipids such as long-chain fatty acids, cholesterol, and squalene (Guest et al., 2004). The primary biological function of this aggregate is to provide a protective, acidic, and antimicrobial environment that lubricates the ear canal and traps foreign debris (Roeser & Ballachanda, 1997). However, when the natural self-cleaning mechanism fails, these aggregates can form an impaction, leading to conductive hearing loss, pain, and tinnitus (Horton et al., 2020). In clinical pharmacology, this mass is the therapeutic target for cerumenolytic agents, which are designed to soften or dissolve the aggregate to facilitate its removal. These agents work through various mechanisms, including the release of nascent oxygen to mechanically disrupt the wax or the use of surfactants to emulsify the lipid components (StatPearls, 2023).

Other names
EarwaxCerumenCeruminous massCerumen impaction
02

Mechanism of action

Cerumenolytics facilitate the disintegration of the aggregate by either inducing oxidative fragmentation, emulsifying lipids, or softening the keratin-lipid matrix through hydration and lubrication.

03

Biological functions

Physical protection of the external auditory canalLubricationAntimicrobial defenseSelf-cleaning mechanismOther
04

Disease associations

Cerumen impactionConductive hearing lossTinnitusOtitis externaOther
05

Safety considerations

Tympanic membrane perforation riskOtotoxicityExternal auditory canal irritationContact dermatitisSecondary infection
06

Interacting drugs

Carbamide peroxide

6 more in the full profile.

07

Biomarkers

Otoscopic visualization of canal occlusionConductive hearing loss via audiometryAir-bone gap on hearing tests

Beyond the preview

Go deeper on Cerumen lipid and keratin aggregates.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cerumen lipid and keratin aggregates.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call